Trial Information
Inclusion Criteria:
- Stable pulmonary sarcoidosis with no change in medication during the last 3 months.
Exclusion Criteria:
- Any significant other pulmonary and\or co-morbidity that can affect exercise
tolerance.
- Chronic steroid treatment more than 5 mg/day.
- Previous lung surgery.
- Advanced heart failure (NYHA III-IV )
- Malignancy during the last 3 years
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Improvment in 6 minute walking distance and VO2/KG max following pulmonary rehabilitation.
Outcome Time Frame:
16 weeks
Safety Issue:
No
Authority:
Israel: Ethics Commission
Study ID:
0019-11-MMC
NCT ID:
NCT01384123
Start Date:
August 2011
Completion Date:
July 2013
Related Keywords:
- Pulmonary Sarcoidosis
- stable pulmonary sarcoidosis with no change in medication during the last 3 months/
- Sarcoidosis
- Sarcoidosis, Pulmonary